SMAD4 gene mutation is not included in the currently used diagnostic criteria for HHT but is tested in cases of strong clinical suspicion of HHT that do not fulfil diagnostic criteria, and when testing family members of HHT patients [31]. This evidence concerns the gene SMAD4 and hereditary hemorrhagic telangiectasia.